Документальный обзор ASEM
Official Canadian Paediatric Society document (2019) on “Improving paediatric medications: A prescription for Canadian children and youth”. In Canada, policies governing medication approval and reimbursement are based largely on adult standards, and the evaluation of new medicines employs adult return-on-investment benchmarks. Research funding for adult diseases is often prioritized over that for childhood illnesses. Canada lags other countries in implementing regulatory and research-related reforms that take the unique characteristics of children and yo.
Это краткое содержание помогает найти нужный документ. В отношении клинических рекомендаций всегда сверяйтесь с официальной версией и датой её обновления.
Официальный документ